Moleculent AB

The Future of Cellular Understanding - Moleculent

Moleculent AB is a biotech company in Solna, Sweden, founded in 2019. It has raised $46.0M across 2 rounds, most recently a $20.0M Series B in April 2026.

Headquarters
Solna
Employees
11–50
Founded
2019
Business Model
B2B
Total Funding
$46.0M
Last Round
$20.0M Series BApr 2026
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 3 investors for this company. to use credits for reveals, or explore the API.

About

Moleculent is adding a functional layer of biology to advance life science. Its technology maps communication between cells in human tissue and provides meaningful data on cellular biology. The platform detects cell-cell interactions directly within their tissue environment, showing how healthy cells function and how diseased cells differ, and granting access to at-scale functional proteomics.

Funding History

Data from Indexed.vcUpdated
Series BSeries BApr 2026
$20.0M

1 more funding event

  • Series A20242 investors

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Marketing & SEO ×4
  • Backend ×1
  • CRM & Sales ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech
Growth EquityTotal funding$2.7BJul 2026
Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Biotech
Series CTotal funding$2.6BNov 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech
Series DTotal funding$1.4BJun 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Moleculent AB on Indexed.vc
<a href="https://indexed.vc/companies/moleculent-ab"><img src="https://indexed.vc/api/badge/company/moleculent-ab" alt="Moleculent AB on Indexed.vc" width="260" height="76" /></a>